Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2012
04/24/2012US8163920 Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
04/24/2012US8163907 Dihydropyridine calcium antagonist compounds, preparation methods, and medical uses thereof
04/24/2012US8163904 Prepared by reacting free base with an acid in methanol under a nitrogen atmosphere; use in treating a disease which responds to an inhibition of protein kinase activity
04/24/2012US8163901 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
04/24/2012US8163793 Proline derivatives
04/24/2012US8163777 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
04/24/2012US8163775 Allosteric modulators of metabotropic glutamate receptors
04/24/2012US8163774 Antidiabetic agents; 2-(amino-substituted piperidin-1-yl)benzimidazoles; N-(4-Chlorobenzyl)-2-(3-aminopiperidin-1-yl)-1-(4-fluorobenzyl)-1H-benzimidazole-6-carboxamide hydrochloride for example; use in combination with other antidiabetic, antilipemic agents
04/24/2012US8163773 Organic compounds
04/24/2012US8163765 Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
04/24/2012US8163757 Immuno inhibitory pyrazolone compounds
04/24/2012US8163756 For example,1-(3-t-butyl-1- (1,2,3,4-tetrahydro- isoquinolin-6-yl)-1H- pyrazol-5-yl)-3-(3- cyanophenyl)urea; for treatment of mammalian cancers and inflammatory diseases including rheumatoid arthritis, retinopathies
04/24/2012US8163752 Tricyclic anilide heterocyclic CGRP receptor antagonists
04/24/2012US8163751 Acylated indanyl amines and their use as pharmaceuticals
04/24/2012US8163743 4-carboxamide indazole derivatives useful as inhibitors of PI3-kinases
04/24/2012US8163733 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
04/24/2012US8163729 Modulators of α7 nicotinic acetylcholine receptors and therapeutic uses thereof
04/24/2012CA2645467C Pyridine derivative having anti-helicobacter pylori activity
04/24/2012CA2559530C Novel benzyl(idene)-lactam derivatives
04/24/2012CA2538743C Benzylbenzimidazolyl derivatives as kinase inhibitors
04/24/2012CA2525373C Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
04/24/2012CA2499322C Benzodiapine derivatives and pharmaceutical compositions containing them
04/24/2012CA2486537C 4-(substituted cycloalkylmethyl)imidazole-2-thiones, 4-(substituted cycloalkenylmethyl)imidazole-2-thiones, 4-(substituted cycloalkylmethyl)imidazol-2-ones and 4-(substituted cycloalkenylmethyl)imidazol-2-ones and related compounds
04/24/2012CA2481926C Heterocyclic compounds which inhibit leukocyte adhesion mediated by .alpha.4 integrins
04/24/2012CA2439149C Acylated piperidine derivatives as melanocortin-4 receptor agonists
04/24/2012CA2408752C Delivery systems for treatment of vascular disease
04/19/2012WO2012051213A2 Therapeutic 5,6,5-tricyclic analogs
04/19/2012WO2012051103A1 Serotonin reuptake inhibitors
04/19/2012WO2012051036A1 Quinazolinone-type compounds as crth2 antagonists
04/19/2012WO2012050183A1 Pyrimidine compound and pesticidal application thereof
04/19/2012WO2012050159A1 Amide derivative and use thereof
04/19/2012WO2012050141A1 Heteroaromatic ring compound and use thereof for pest control
04/19/2012WO2012050041A1 Aryloxyurea compound and pest control agent
04/19/2012WO2012049828A1 Aromatic heterocyclic derivative, and organic electroluminescent element comprising same
04/19/2012WO2012049277A1 Cxcr4 receptor antagonists
04/19/2012WO2012049190A1 N-pyridin-3-yl or n-pyrazin-2-yl carboxamides
04/19/2012WO2012048775A1 Pyrrolidinones as metap2 inhibitors
04/19/2012WO2012048411A1 Plk-4 inhibitors and method of treating cancer with same
04/19/2012WO2011163636A3 Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms
04/19/2012WO2011159839A3 Thioacetate compounds, compositions and methods of use
04/19/2012WO2011158176A3 Gold complexes for use in the treatment of cancer
04/19/2012WO2011156775A3 8-(2'-heterocycyl)pyrido[2.3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
04/19/2012WO2011150156A3 Heteroaryl compounds and methods of use thereof
04/19/2012WO2011116161A3 Arylsulfonamide ccr3 antagonists
04/19/2012WO2011051198A3 Pyridine derivatives as agricultural pesticides
04/19/2012WO2009137538A3 Fungicidal substituted azoles
04/19/2012US20120095229 Chemical process
04/19/2012US20120095057 Pyrazole compound
04/19/2012US20120095056 2,5-disubstituted tetrazole derivatives and their use as nicotinic acetylcholine receptor modulators
04/19/2012US20120095055 HEXAHYDROCYCLOPENTYL[f]INDAZOLE 5-HYDROXYMETHYL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
04/19/2012US20120095054 Polymorphs of esomeprazole salts
04/19/2012US20120095053 Aminotetrahydroindazoloacetic acids
04/19/2012US20120095051 Curcumin analogues as zinc chelators and their uses
04/19/2012US20120095049 Nociceptin analogs
04/19/2012US20120095047 Novel Heteropyrrole Analogs Acting on Cannabinoid Receptors
04/19/2012US20120095041 Reversible nondepolarizing neuromuscular blockade agents and methods for their use
04/19/2012US20120095039 Heterocyclic compounds with affinity to muscarinic receptors
04/19/2012US20120095031 Cyclopropane compound
04/19/2012US20120095023 Novel Heterocyclic Compounds as Pesticides
04/19/2012US20120095012 Toluidine sulfonamides and their use
04/19/2012US20120095011 Novel compounds
04/19/2012US20120095007 Carbamoyloxy arylalkan arylpiperazine analgesics
04/19/2012US20120095006 Treatment of pulmonary hypertension
04/19/2012US20120095000 Compounds for activating tgf-beta signaling
04/19/2012US20120094999 Egfr inhibitors and methods of treating disorders
04/19/2012US20120094997 Substituted hydroxamic acids and uses thereof
04/19/2012US20120094993 N-pyridin-3-yl or n-pyrazin-2-yl carboxamides
04/19/2012US20120094989 5-ht receptor modulating compounds
04/19/2012US20120094986 Anticancer deriviatives, preparation thereof, and therapeutic use thereof
04/19/2012US20120094981 Anthelmintic agents and their use
04/19/2012US20120094980 Pyridyl inhibitors of hedgehog signalling
04/19/2012US20120094977 Compositions and methods for the treatment of disease associated with trp-p8 expression
04/19/2012US20120094976 New chemical compounds
04/19/2012US20120094972 Heterocyclic compounds and their uses
04/19/2012US20120094968 Sulfonic amide and sulfoximine-substttuted diaryl-dihydropyrimidinones and usage thereof
04/19/2012US20120094964 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
04/19/2012US20120094958 Quinolines as inhibitors of farnesyl pyrophosphate synthase
04/19/2012US20120094943 Alpha 7 nicotinic receptor selective ligands
04/19/2012US20120094837 Novel Heterocyclic Compounds as Pesticides
04/19/2012US20120094830 Anthranilic acid diamide derivative with hetero-aromatic and hetero-cyclic substituents
04/19/2012US20120091446 Compound for optoelectronic device, organic light emitting diode including the same and display including the organic light emitting diode
04/19/2012US20120091445 Compound for organic optoelectronic device, organic light emitting diode including the same, and display device including the organic light emitting diode
04/19/2012CA2814503A1 Substituted benzamides and their uses
04/19/2012CA2814419A1 Cxcr4 receptor antagonists
04/19/2012CA2814369A1 Pyrrolidinones as metap-2 inhibitors
04/19/2012CA2813908A1 Aryloxyurea compound and pest control agent
04/19/2012CA2813520A1 N-pyridin-3-yl or n-pyrazin-2-yl carboxamides
04/19/2012CA2811641A1 Serotonin reuptake inhibitors
04/18/2012EP2441763A1 Benzylpiperazine derivatives useful for the treatment of gastrointestinal disorders
04/18/2012EP2441762A1 Potentiators of Glutamate Receptors
04/18/2012EP2441755A1 Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
04/18/2012EP2440547A2 Compounds useful for treating aids
04/18/2012EP2440546A2 Compounds useful for treating premature aging and in particular progeria
04/18/2012EP2440545A2 Compounds useful for treating cancer
04/18/2012EP2440544A1 Hedgehog pathway antagonists and therapeutic applications thereof
04/18/2012EP2440543A2 Improved method for synthesizing pirfenidone
04/18/2012EP2440542A1 Substituted benzimidazoles, benzothiazoles and benzoxazoles
04/18/2012EP2440541A1 Novel fused cyclic compound and use thereof
04/18/2012EP2440534A2 Pyrimidine derivatives as zap-70 inhibitors
04/18/2012EP2440529A1 Janus kinase inhibitor compounds and methods
1 ... 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 ... 1080